Case Study Data With A Developmental Fxa Inhibitor

Beyond the published literature that is available, data and personal observations collected during the development of another FXa inhibitor at Pfizer Global Research & Development are now provided to complete this case study approach to biomarker utilization during anticoagulant development. Development of this particular FXa inhibitor ultimately was discontinued, as this compound required intravenous administration and as such lacked marketability compared to oral FXa inhibitors. However, the lessons learned provide further documentation of species-specific and interpretational complications that arise with the utilization of accepted coagulation biomarkers to monitor anticoagulant efficacy and safety for FXa inhibitors.

Project Management Made Easy

Project Management Made Easy

What you need to know about… Project Management Made Easy! Project management consists of more than just a large building project and can encompass small projects as well. No matter what the size of your project, you need to have some sort of project management. How you manage your project has everything to do with its outcome.

Get My Free Ebook

Post a comment